The expression of miR-340, which is also predicted to target GLUT1, is epigenetically silenced by DNA methylation in MM [286,308], and low expression of miR-340 has been previously associated with a poor outcome in AML [309]. This evidence concerns the gene SLC2A1 and Miyoshi myopathy.